si:ch211-105d11.2 Antibody

What is si:ch211-105d11.2 and how is it related to other genes in the si:ch211 family?

si:ch211-105d11.2 belongs to a family of genes identified through zebrafish genomic sequencing projects. While specific information on si:ch211-105d11.2 is limited in current literature, comparative analysis with related family members such as si:ch211-105d11.3 provides valuable insights. The si:ch211-105d11.3 gene encodes an mRNA cap guanine-N7 methyltransferase with the human orthologue RNMT and mouse orthologue Rnmt . The si:ch211 designation refers to the bacterial artificial chromosome (BAC) clone from which these sequences were identified. Given the sequential naming convention, si:ch211-105d11.2 likely resides in proximity to si:ch211-105d11.3 on chromosome 19.

What expression patterns have been documented for si:ch211-105d11.2 during zebrafish development?

Expression patterns for si:ch211-105d11.2 must be interpreted in context with related family members. Based on studies of similar zebrafish genes, expression is typically analyzed through in situ hybridization at key developmental timepoints (24 hpf, 48 hpf, 72 hpf, and 5 dpf). Researchers should consider temporal regulation patterns when designing antibody-based detection experiments, as expression levels may vary significantly across developmental stages. When designing experiments, reference the expression patterns of related genes like si:ch211-105d11.3, which shows specific temporal patterns related to its methyltransferase function .

How do mutations in si:ch211-105d11.2 affect zebrafish development and physiology?

Understanding mutant phenotypes provides crucial context for antibody-based studies. By examining the mutation data available for related genes like si:ch211-105d11.3, researchers can develop hypotheses about si:ch211-105d11.2 function. The si:ch211-105d11.3 gene has three documented alleles with different mutation types:

When studying si:ch211-105d11.2, researchers should consider generating or obtaining similar mutation panels to correlate antibody staining patterns with loss-of-function phenotypes.

What are the critical considerations for developing specific antibodies against si:ch211-105d11.2?

Developing specific antibodies against si:ch211-105d11.2 requires careful epitope selection to minimize cross-reactivity with related family members. Begin by performing sequence alignment analysis between si:ch211-105d11.2 and other si:ch211 family proteins to identify unique regions. Ideal epitopes should be 10-20 amino acids in length, surface-exposed, and contain minimal post-translational modifications. For zebrafish proteins specifically, researchers should avoid highly conserved domains if studying a single family member. Consider generating antibodies against multiple epitopes to increase validation options and application flexibility.

How should researchers validate antibodies against si:ch211-105d11.2?

Rigorous validation is essential for ensuring antibody specificity, particularly for zebrafish genes with potential paralogues. A comprehensive validation approach includes:

• Western blot analysis using:

  • Wild-type zebrafish tissue expressing si:ch211-105d11.2

  • Tissues from zebrafish with mutations in si:ch211-105d11.2 (similar to the mutation panel seen for si:ch211-105d11.3)

  • Recombinant si:ch211-105d11.2 protein as a positive control

• Immunohistochemistry with parallel in situ hybridization to confirm co-localization of protein and mRNA signals.

• Immunoprecipitation followed by mass spectrometry to confirm antibody is pulling down the correct protein.

• Cross-reactivity testing against closely related family members, particularly si:ch211-105d11.3, given its documented similarity in BAC clone origin .

What are the optimal protocols for immunohistochemistry using si:ch211-105d11.2 antibodies?

For successful immunohistochemistry with si:ch211-105d11.2 antibodies in zebrafish tissues, follow these methodological guidelines:

• Fixation: 4% paraformaldehyde for 24 hours at 4°C is standard for zebrafish embryos and adult tissues. For adult tissues, consider extending fixation time to 48 hours.

• Antigen retrieval: Test both heat-mediated (citrate buffer, pH 6.0) and enzymatic (proteinase K) retrieval methods, as the optimal approach depends on the specific epitope recognized by your antibody. For zebrafish tissues, heat-mediated retrieval at 85°C for 15-20 minutes often provides better results than higher temperatures used for mammalian tissues.

• Blocking: Use 10% normal goat serum with 1% BSA and 0.3% Triton X-100 in PBS for 2 hours at room temperature to minimize background staining.

• Primary antibody: Begin with a dilution series (1:100, 1:500, 1:1000) and incubate overnight at 4°C. Wash thoroughly with PBS containing 0.1% Tween-20.

• Signal amplification: Consider tyramide signal amplification for detecting low-abundance proteins, which is particularly relevant for developmental studies where expression may be temporally restricted.

How can si:ch211-105d11.2 antibodies be effectively used in Western blot applications?

Western blot protocols for zebrafish proteins require specific modifications for optimal results:

• Sample preparation: When processing zebrafish tissues, use a lysis buffer containing phosphatase and protease inhibitors (RIPA buffer with 1 mM PMSF, 1 μg/ml aprotinin, 1 μg/ml leupeptin, 1 mM Na3VO4, and 1 mM NaF).

• Protein separation: Utilize gradient gels (4-15%) to ensure optimal separation and accommodate the possibility that si:ch211-105d11.2 may undergo post-translational modifications.

• Transfer conditions: For zebrafish proteins, wet transfer at 30V overnight at 4°C often yields better results than rapid transfer protocols.

• Blocking: 5% non-fat dry milk in TBST for 1 hour at room temperature, followed by primary antibody incubation at optimal dilution (typically starting at 1:1000).

• Controls: Include positive controls (tissues known to express si:ch211-105d11.2) and negative controls (si:ch211-105d11.2 mutant tissues if available, similar to the mutation variants documented for si:ch211-105d11.3) .

What are common pitfalls when working with antibodies against zebrafish proteins like si:ch211-105d11.2?

Several technical challenges can arise when working with antibodies against zebrafish proteins:

• Cross-reactivity with paralogs: Zebrafish underwent genome duplication during evolution, resulting in multiple paralogs that may cross-react with antibodies. Test antibody specificity against related proteins, particularly other si:ch211 family members.

• Developmental stage specificity: Expression of si:ch211-105d11.2 may vary throughout development. If negative results are obtained, verify testing across different developmental timepoints (24 hpf, 48 hpf, 72 hpf, 5 dpf, and adult stages).

• Tissue-specific post-translational modifications: These can affect epitope accessibility. Consider using multiple antibodies targeting different regions of the protein to ensure detection.

• Fixation artifacts: Zebrafish tissues may respond differently to fixatives compared to mammalian tissues. If signal is weak or absent, systematically test alternative fixation protocols (e.g., Dent's fixative or methanol fixation as alternatives to paraformaldehyde).

• Autofluorescence: Zebrafish yolk can produce significant autofluorescence. Implement Sudan Black B treatment (0.1% in 70% ethanol) after secondary antibody incubation to reduce background.

How can researchers troubleshoot weak or absent signals when using si:ch211-105d11.2 antibodies?

When encountering weak or absent signals, implement the following troubleshooting strategy:

• Antibody concentration: Perform a systematic titration from 1:100 to 1:2000 to identify optimal dilution.

• Epitope exposure: Extend antigen retrieval time or test alternative methods. For heat-mediated retrieval, test pH ranges from 6.0 to 9.0 to identify optimal conditions.

• Signal amplification: Implement tyramide signal amplification or biotin-streptavidin systems if conventional detection methods yield weak signals.

• Tissue permeabilization: For whole-mount applications, increase permeabilization with 0.5-1% Triton X-100 pretreatment for 1-2 hours.

• Genetic verification: Generate or obtain si:ch211-105d11.2 mutant lines as negative controls, similar to the documented alleles for si:ch211-105d11.3 (sa44910, sa23481, sa5919) .

How can si:ch211-105d11.2 antibodies be applied in co-localization studies with other zebrafish proteins?

For sophisticated co-localization experiments investigating si:ch211-105d11.2:

• Antibody compatibility: When performing double immunofluorescence, select antibodies raised in different host species to prevent cross-reactivity of secondary antibodies. If antibodies are from the same host, consider direct conjugation or sequential immunostaining with intermediate blocking steps.

• Spectral separation: For confocal microscopy, ensure fluorophores have minimal spectral overlap. For zebrafish, where autofluorescence can be problematic, far-red fluorophores (e.g., Alexa Fluor 647) often provide better signal-to-noise ratios.

• Sequential scanning: Utilize sequential scanning rather than simultaneous detection to minimize bleed-through, particularly when working with closely related emission spectra.

• Validation: Confirm co-localization using super-resolution techniques such as STED or STORM, which provide better spatial resolution than conventional confocal microscopy.

• Controls: Include single-label controls to confirm specificity and quantify potential bleed-through using Pearson's or Mander's correlation coefficients.

What approaches can be used for studying si:ch211-105d11.2 in the context of chromatin association?

For investigating potential chromatin associations of si:ch211-105d11.2:

• Chromatin immunoprecipitation (ChIP): Optimize crosslinking conditions specifically for zebrafish tissues (1% formaldehyde for 10 minutes at room temperature is a standard starting point). Sonication conditions must be optimized for zebrafish chromatin, typically requiring less energy than mammalian samples.

• ChIP-seq analysis: Design appropriate sequencing depth (minimum 20 million reads) and utilize zebrafish-specific genome builds (GRCz11 is current) for alignment. For related genes like si:ch211-105d11.3, researchers should note specific genomic coordinates (Chromosome 19, position 12655414 in GRCz11) .

• CUT&RUN as an alternative: For proteins with weak chromatin association, CUT&RUN may provide better signal-to-noise ratio than traditional ChIP.

• Visualization: Integrate ChIP-seq data with RNA-seq and ATAC-seq data to correlate binding sites with gene expression and chromatin accessibility.

• Validation: Confirm key binding sites with ChIP-qPCR using primers designed specifically for the zebrafish genome.

How does si:ch211-105d11.2 compare to its human and mouse orthologues?

Understanding evolutionary relationships provides critical context for antibody-based studies:

• Orthologue identification: Based on related genes like si:ch211-105d11.3, which has the human orthologue RNMT and mouse orthologue Rnmt , researchers should perform comprehensive sequence analysis to identify potential orthologues of si:ch211-105d11.2.

• Domain conservation: Analyze the conservation of functional domains across species to identify regions most likely to maintain similar functions between zebrafish and mammals.

• Expression pattern comparison: Compare expression patterns across species using resources like ZFIN for zebrafish, MGI for mouse, and GTEx for humans to identify conserved tissue-specific expression.

• Cross-reactivity potential: When validating antibodies, test against recombinant human and mouse orthologues to assess potential for cross-species applications.

• Functional complementation: Consider testing whether human/mouse orthologues can rescue phenotypes in zebrafish si:ch211-105d11.2 mutants as a definitive test of functional conservation.

What are the methodological considerations for differentiating between closely related si:ch211 family members?

For distinguishing between closely related family members:

• Epitope selection: Generate antibodies against the least conserved regions between family members, identified through comprehensive sequence alignment of si:ch211-105d11.2 and related proteins.

• Validation with genetic controls: Utilize mutant lines for each family member (such as the documented alleles sa44910, sa23481, and sa5919 for si:ch211-105d11.3) to confirm antibody specificity.

• Peptide competition assays: Perform peptide competition with specific and related peptides to demonstrate antibody specificity.

• Mass spectrometry validation: Confirm antibody specificity through immunoprecipitation followed by mass spectrometry, which can unambiguously identify the target protein.

• Multiplexed detection: Develop protocols for simultaneous detection of multiple family members using antibodies with different host species origins or directly conjugated to distinct fluorophores.